Filing Details
- Accession Number:
- 0001181431-14-025043
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-26 11:46:16
- Reporting Period:
- 2014-06-25
- Filing Date:
- 2014-06-26
- Accepted Time:
- 2014-06-26 11:46:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1533040 | Rxi Pharmaceuticals Corp | RXII | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1285648 | Geert Cauwenbergh | C/O Rxi Pharmaceuticals Corporation 257 Simarano Drive, Suite 101 Marlborough MA 01752 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 Par Value | Acquisiton | 2014-06-25 | 500 | $3.01 | 26,600 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
